Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

864284

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Reviews
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary State for Health and Social Care, whether the NHS (a) fit and proper person requirement and (b) duty of candour applies to an individual who undertakes an independent review commissioned by an NHS body that is funded by his Department.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	132768
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>The fit and proper person requirement requires all registered health and adult social care providers to make sure board directors, board members and individuals who perform the functions equivalent to the functions of a board director and member, are fit for their roles. The Care Quality Commission (CQC) assesses whether registered providers have appropriate processes in place for this. In this regard the CQC does not look at individuals, an approach which would extend to independent reviewers.</p><p> </p><p>The statutory duty of candour applies to organisations, rather than to individual members of staff. All regulated healthcare professionals working in the United Kingdom have an individual professional duty of candour, which is a responsibility to be open and honest. This responsibility is set out in their respective professional codes of conduct. The duty of candour set out in professional codes of conduct would therefore not automatically extend to independent reviewers, but any reviewer would be expected to be independent and able to express views with candour.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/03/2018 17:02:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1538 label Biography information for Rosie Cooper

864292

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Reviews
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether there are mechanisms in place to provide oversight of independent reviews commissioned by NHS bodies that are funded by his Department.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	132776
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>The Department maintains an oversight of independent investigations carried out by its National Health Service arm’s-length bodies. This forms part of its sponsorship role whereby the Department holds these bodies to account for performance, delivering value for money services and supporting the Department in achieving its objectives.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/03/2018 10:56:42 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1538 label Biography information for Rosie Cooper

864293

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	East Lancashire Clinical Commissioning Group: Salute
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations his Department has received on recent work undertaken by East Lancashire Clinical Commissioning Group and the charity Salute.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	132777
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>NHS England has advised that following the hon. Member’s letter to the Chief Executive of NHS England, they have launched an investigation.</p><p> </p><p>They also have advised that they are unable to provide further information until the investigation is concluded.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2018 16:42:20 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper

864295

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he will assess the potential merits of introducing a separate assessment process for rare disease medicines that do not meet the criteria set out by the National Institute of Health and Care Excellence for their Highly Specialised Technology route.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	132779
answer	answer is ministerial correction date of answer 23/03/2018 answer text <p>The Department has no plans to establish a new assessment process for the evaluation of rare disease treatments. The National Institute for Health and Care Excellence (NICE) develops guidance on most new drugs through its technology appraisal programme, and has been able to recommend a number of drugs for rare diseases for routine use on the National Health Service.</p><p> </p><p>There is an established topic selection process for the technology appraisal and highly specialised technology evaluation programme that includes a public consultation and is designed to ensure that treatments are only referred for assessment by NICE where its guidance will add value. NICE periodically reviews its methods and processes to ensure that they remain fit for purpose for the NHS in England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/03/2018 14:15:12 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

864302

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Carillion: Insolvency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 March 2018 to Question 129143 on Carillion: Insolvency, what discussions he has had with representative of Royal Liverpool University Hospital on a new contractor for the completion of the new Royal Liverpool University Hospital since 1 March 2018.
tabling member constituency	Liverpool, Riverside
tabling member printed	Mrs Louise Ellman
uin	132786
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>The Private Finance Initiative (PFI) contract between the Royal Liverpool and Broadgreen University Hospitals NHS Trust and the PFI Project Company is still in place, which means that the Company is still contractually obliged to manage the project and find a construction firm or subcontractor who can continue the building work.</p><p> </p><p>The Royal Liverpool Hospital scheme is very well advanced. The PFI Project Company is continuing its discussions with PwC (on behalf of the official receiver), their lenders and with other service and construction companies to assess how best to continue delivering the contract. Officials from the Department and NHS Improvement are working very actively with all the parties to keep the delay as short as possible and provide the best value for money solution for the Trust and for the public sector as a whole.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 20/03/2018 16:59:24 answering member 4095 label Biography information for Steve Barclay
tabling member	484 label Biography information for Dame Louise Ellman

864305

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Health Care: Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to monitor the effect of new guidance issued by NHS England relating to items that should not routinely be prescribed in primary care on trends in the levels of prescriptions in primary care.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	132789
answer	answer is ministerial correction date of answer 22/03/2018 answer text <p>NHS England held a three month consultation between July and October 2017 on draft guidance for clinical commissioning groups’ (CCGs’) proposed restrictions on the routine prescribing of 18 products, totalling £141 million in National Health Service primary care spend. Final statutory guidance ‘Items which should not be routinely prescribed in primary care: Guidance for CCGs’ was published on 30 November 2017.</p><p> </p><p>NHS England is responsible for monitoring the effect of its new guidance relating to items that should not routinely be prescribed in primary care. NHS England does not hold information on how many CCG guidelines have been updated, or how much funding has been saved since the guidance was published. The NHS Business Services Authority has a dashboard which monitors, on a monthly basis, prescribing volume and costs of the 18 products identified in the CCG guidance. NHS England plans to utilise this dashboard to monitor implementation and progress.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 132629 question first answered 22/03/2018 17:22:56 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper

864309

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Schools
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many children have been refused access to a school nurse since the introduction of the NHS (Charges to Overseas Visitors) (Amendment) Regulations 2017.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	132793
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>This information is not collected. However, services provided by school nurses and health visitors remain outside the scope of the Charging Regulations and so access to these services should not be refused.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 20/03/2018 17:02:22 answering member 4095 label Biography information for Steve Barclay
tabling member	4244 label Biography information for Jonathan Ashworth

864311

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the effect of making efficiencies in the cost of medicines on research investment by the pharmaceutical industry.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	132795
answer	answer is ministerial correction date of answer 23/03/2018 answer text <p>Independent research has found that the primary drivers of research investment decisions by the pharmaceutical industry are supply side factors such as the skills and science base of the country in question. The price the National Health Service pays for medicines has been found to have a much less significant impact on company investment decisions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/03/2018 14:19:43 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

864316

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on the wellbeing of children who may be permitted to change gender below the age of 18 without parental consent.
tabling member constituency	Lagan Valley
tabling member printed	Sir Jeffrey M. Donaldson
uin	132800
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>Valid consent to treatment is a central to all forms of healthcare, from providing personal care to undertaking major surgery. If a child is not competent to give consent for themselves, consent should be sought from a person with parental responsibility. This will often, but not always, be the child’s parent.</p><p> </p><p>Decisions about whether to give medical treatment in such cases before the age of 18 without parental consent are properly a matter for clinical judgment, having regard to the best interests and wellbeing of the patient. In exercising their judgment, clinicians will be guided by various pieces of evidence based guidance, such as that published in 2017, Endocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. This is available on the National Institute for Health and Care Excellence website at the following link:</p><p> </p><p><a href="https://www.evidence.nhs.uk/search?q=Transgender+conditions" target="_blank">https://www.evidence.nhs.uk/search?q=Transgender+conditions</a></p><p> </p><p>This guideline recognizes that there may be compelling reasons to initiate sex hormone treatment prior to age 16 years, but notes that there are minimal published experience treating prior to 13.5 to 14 years of age. For the care of peri-pubertal youths and older adolescents, the guideline recommends that an expert multidisciplinary team comprised of medical professionals and mental health professionals manage this treatment.</p><p> </p><p>Any child under 18 thought to have gender dysphoria will usually be referred to a specialist child and adolescent Gender Identity Clinic. Staff at these clinics can carry out a detailed assessment of the child, to help them determine what support they need. Depending on the results of this assessment, the options for children and young people with suspected gender dysphoria can include family therapy, individual child psychotherapy and hormone therapy.</p><p> </p><p>Psychological support offers young people and their families a chance to discuss their thoughts and receive support to help them cope with the emotional distress of the condition, without rushing into more drastic treatments. Further information on the laws and guidelines that protect transsexual people and outline how they should be treated by medical professionals is available on the NHS Choices website at:</p><p> </p><p><a href="https://www.nhs.uk/conditions/gender-dysphoria/guidelines/" target="_blank">https://www.nhs.uk/conditions/gender-dysphoria/guidelines/</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/03/2018 17:04:55 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	650 label Biography information for Sir Jeffrey M Donaldson

864329

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to amend the list of long-term and orphan diseases which qualify for free prescriptions; and when he last consulted (a) patients, (b) doctors and (c) those in the (i) pharmaceutical and (ii) health industries on that subject.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	132813
answer	answer is ministerial correction date of answer 23/03/2018 answer text <p>We have no current plans to amend the list of long-term and orphan diseases which qualify for free prescriptions. The last consultation on this issue was as part of Professor Sir Ian Gilmore’s review in 2008, which included consultation with patients, the public and general practitioners.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/03/2018 14:18:42 answering member 4067 label Biography information for Steve Brine
tabling member	4637 label Biography information for James Frith